Stay updated on ABRAZO Clinical Trial
Sign up to get notified when there's something new on the ABRAZO Clinical Trial page.

Latest updates to the ABRAZO Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThis update introduces Revision: v3.4.2 and removes Revision: v3.4.1, along with a notice about government funding and operating status, which are routine site maintenance changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding was added, and the page revision updated from v3.4.0 to v3.4.1; this does not affect the study details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedThe changes include a new 'Show glossary' option, capitalization tweaks (e.g., Met QC Criteria, data), and a Revision: v3.4.0 notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision label on the page updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a consolidated Locations section listing site locations by region (California, Florida, Indiana, Maryland, New York, Tennessee, Texas, Bavaria, Rhineland-Palatinate, Saxony, England, Lancashire). Removed the HHS Vulnerability Disclosure footer link and updated the page revision tag to v3.3.3.SummaryDifference0.9%

- Check85 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to ABRAZO Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABRAZO Clinical Trial page.